| Aug 8 |
Quoin Pharmaceuticals reports Q2 results
|
| Aug 8 |
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results
|
| Aug 6 |
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
|
| Aug 1 |
Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
| Jun 27 |
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
|
| Jun 25 |
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
|
| Jun 12 |
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
|
| May 22 |
QNRX: Protocol Modifications Potentially Accelerate, Expand QRX003 Approvals
|
